Medical Journals

Structure-based Optimization of Protein Tyrosine Phosphatase 1b Inhibitors: from the Active Site to the Second Phosphotyrosine Binding Site.

Authors:
  • Wilson Douglas P
  • Wan Zhao-Kui
  • Xu Wei-Xin
  • Kirincich Steven J
  • Follows Bruce C
  • Joseph-McCarthy Diane
  • Foreman Kenneth
  • Moretto Alessandro
  • Wu Junjun
  • Zhu Min
  • Binnun Eva
  • Zhang Yan-Ling
  • Tam May
  • Erbe David V
  • Tobin James
  • Xu Xin
  • Leung Louis
  • Shilling Adam
  • Tam Steve Y
  • Mansour Tarek S
  • Lee Jinbo

From: Chemical and Screening Sciences, and Cardiovascular and Metabolic Diseases, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, USA.

Journal of medicinal chemistry

  • Publish Date: Sep 2007
  • ISSN: 0022-2623
  • Volume: 50
  • Issue: 19
  • Pages: 4681-98
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wilson Douglas P, Wan Zhao-Kui, Xu Wei-Xin, et al. Structure-based Optimization of Protein Tyrosine Phosphatase 1b Inhibitors: from the Active Site to the Second Phosphotyrosine Binding Site.. J. Med. Chem. Sep 2007;50:4681-98

Abstract

Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin and leptin receptor pathways and thus an attractive therapeutic target for diabetes and obesity. Starting with a high micromolar lead compound, structure-based optimization of novel PTP1B inhibitors by extension of the molecule from the enzyme active site into the second phosphotyrosine binding site is described. Medicinal chemistry, guided by X-ray complex structure and molecular modeling, has yielded low nanomolar PTP1B inhibitors in an efficient manner. Compounds from this chemical series were found to be actively transported into hepatocytes. This active uptake into target tissues could be one of the possible avenues to overcome the poor membrane permeability of PTP1B inhibitors.

Mesh Headings (Keywords): Animals, Binding Sites, Caco-2 Cells, Catalytic Domain, Cell Membrane Permeability, Crystallography, X-Ray, Half-Life, Hepatocytes, Humans, Male, Mice, Mice, Inbred C57BL, Microsomes, Liver, Models, Molecular, Molecular Structure, Phosphotyrosine, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Protein Tyrosine Phosphatases, Rats, Rats, Sprague-Dawley, Solubility, Structure-Activity Relationship, Thiophenes, Tissue Distribution


Check for Full Text / PubMed Unique Identifier (PMID): 17705360


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.